1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

Research Funding and the Long Road to Drug Discovery

Vaccine

Here is a very interesting article about the man behind Alimta, the first FDA approved drug for mesothelioma treatment.  “His find became tumors’ nemesis”

This article highlights and confirms our need to continue to grow the Mesothelioma Applied Research Foundation’s Research Grant Program.  Through our proven peer-review process, we are able to identify the best possible projects and disperse funds quickly and efficiently.  Most recently, the fruits of our labor have become increasingly evident, as more clinical trials based on our basic lab funding are becoming available to mesothelioma patients. We are relying on your generous contributions to help us achieve the progress needed to help mesothelioma patients today.  To contribute, please contact our office at (877) 363-6376 (END-MESO) or visit our donation page.

Also...

In Other News

Clinical Trials

Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different

Read More »

Peritoneal Surgery/HIPEC

Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC).  This session

Read More »

Share:

Facebook
Twitter
LinkedIn